Trials / Recruiting
RecruitingNCT06571669
BOOM-IBD2 Pivotal Clinical Trial
BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 137 (estimated)
- Sponsor
- Boomerang Medical · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The BOOM-IBD2 clinical trial is designed to evaluate the effectiveness of sacral neuromodulation for the treatment of IBD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neuromodulation | Neuromodulation |
Timeline
- Start date
- 2025-01-31
- Primary completion
- 2026-02-01
- Completion
- 2026-10-01
- First posted
- 2024-08-26
- Last updated
- 2025-07-03
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06571669. Inclusion in this directory is not an endorsement.